{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:44:20Z","timestamp":1790433860491,"version":"4.1.0"},"reference-count":572,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2014.00231","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T12:32:51Z","timestamp":1414758771000},"source":"Crossref","is-referenced-by-count":134,"title":["How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion"],"prefix":"10.3389","volume":"5","author":[{"given":"Douglas B.","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1124\/dmd.113.055632","article-title":"Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1124\/dmd.109.028654","article-title":"Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs","volume":"37","author":"Ahlin","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.tibtech.2012.05.006","article-title":"Mass spectrometry imaging is moving toward drug protein co-localization","volume":"30","author":"Ait-Belkacem","year":"2012","journal-title":"Trends Biotechnol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2217\/pme.10.63","article-title":"Pharmacogenomics and adverse drug reactions","volume":"7","author":"Amur","year":"2010","journal-title":"Pers. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0928-0987(03)00169-6","article-title":"Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays","volume":"21","author":"Anderle","year":"2004","journal-title":"Eur. J. Pharm. Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1152\/physiol.00027.2010","article-title":"Hijacking solute carriers for proton-coupled drug transport","volume":"25","author":"Anderson","year":"2010","journal-title":"Physiology (Bethesda)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20977","DOI":"10.1074\/jbc.M610692200","article-title":"Determinants of the anesthetic sensitivity of two-pore domain acid-sensitive potassium channels: molecular cloning of an anesthetic-activated potassium channel from Lymnaea stagnalis","volume":"282","author":"Andres-Enguix","year":"2007","journal-title":"J. Biol. Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/00365520902745039","article-title":"Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions","volume":"44","author":"Andersson","year":"2009","journal-title":"Scand. J. Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/ijms11041403","article-title":"Escherichia coli mar and acrAB mutants display no tolerance to simple alcohols","volume":"11","author":"Ankarloo","year":"2010","journal-title":"Int. J. Mol. Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3109\/0284186X.2012.744140","article-title":"Pancreatic cancer - cost for overtreatment with gemcitabine","volume":"52","author":"Ansari","year":"2013","journal-title":"Acta Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0005-2736(02)00403-0","article-title":"Cloaking cytolytic peptides for liposome-based detection and potential drug delivery","volume":"1564","author":"Aojula","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10637-012-9867-x","article-title":"Population pharmacokinetic modeling of sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanoma","volume":"31","author":"Aoyama","year":"2013","journal-title":"Invest. New Drugs"},{"key":"B15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0026-895X(24)23181-3","article-title":"Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes","volume":"55","author":"Apiwattanakul","year":"1999","journal-title":"Mol. Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrd3375","article-title":"Trial watch: phase III and submission failures: 2007\u00e2\u20ac\u201c2010","volume":"10","author":"Arrowsmith","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","article-title":"Trial watch: phase II and phase III attrition rates 2011\u00e2\u20ac\u201c2012","volume":"12","author":"Arrowsmith","year":"2013","journal-title":"Nat. Rev. Drug Discov"},{"key":"B18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/clpt.2011.13","article-title":"A new trend in personalized medicine: rapid detection of SNPs in drug transporter genes by the SmartAmp method","volume":"89","author":"Aw","year":"2011","journal-title":"Clin. Pharmacol. Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/cmdc.200700036","article-title":"Modeling promiscuity based on in vitro safety pharmacology profiling data","volume":"2","author":"Azzaoui","year":"2007","journal-title":"ChemMedChem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.ddtec.2014.03.008","article-title":"Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters","volume":"12","author":"Bagal","year":"2014","journal-title":"Drug Discov. Today Technol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pharmtox-011112-140248","article-title":"Systems pharmacology to predict drug toxicity: integration across levels of biological organization","volume":"53","author":"Bai","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"Baldwin","year":"2004","journal-title":"Pflugers Arch"},{"key":"B23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0005-2736(80)90156-X","article-title":"Uptake of the lipophilic cation dibenzyldimethylammonium into Saccharomyces cerevisiae. Interaction with the thiamine transport system","volume":"597","author":"Barts","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11731","DOI":"10.1073\/pnas.1109035108","article-title":"Knocking out the door to tunicamycin entry","volume":"108","author":"Bassik","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cbpa.2006.10.040","article-title":"Sequencing single molecules of DNA","volume":"10","author":"Bayley","year":"2006","journal-title":"Curr. Opin. Chem. Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2217\/pgs.09.37","article-title":"Pharmacogenomics of adverse drug reactions: practical applications and perspectives","volume":"10","author":"Becquemont","year":"2009","journal-title":"Pharmacogenomics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1039\/b409813g","article-title":"Molecular similarity: a key technique in molecular informatics","volume":"2","author":"Bender","year":"2004","journal-title":"Org. Biomol. Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1742-7843.2009.00498.x","article-title":"Predicting drug disposition via application of a biopharmaceutics drug disposition classification system","volume":"106","author":"Benet","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11095-007-9523-x","article-title":"The use of BDDCS in classifying the permeability of marketed drugs","volume":"25","author":"Benet","year":"2008","journal-title":"Pharm. Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/ACO.0b013e328354fda8","article-title":"Induced changes in protein receptors conferring resistance to anesthetics","volume":"25","author":"Bertaccini","year":"2012","journal-title":"Curr. Opin. Anesthesiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1021\/ci100266c","article-title":"Modeling anesthetic binding sites within the glycine alpha one receptor based on prokaryotic ion channel templates: the problem with TM4","volume":"50","author":"Bertaccini","year":"2010","journal-title":"J. Chem. Inf. Model"},{"key":"B33","first-page":"319","article-title":"The Konstanz Information Miner,","volume-title":"Studies in Classification, Data Analysis, and Knowledge Organization (GfKL 2007)","author":"Berthold","year":"2007"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.bpj.2011.02.002","article-title":"Membrane interface composition drives the structure and the tilt of the single transmembrane helix protein PMP1: MD studies","volume":"100","author":"Beswick","year":"2011","journal-title":"Biophys. J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-10-2736","article-title":"CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells","volume":"71","author":"Bhutia","year":"2011","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1124\/dmd.111.043489","article-title":"In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation","volume":"40","author":"Bi","year":"2012","journal-title":"Drug Metab. Dispos"},{"key":"B37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng.2471","article-title":"MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors","volume":"45","author":"Birsoy","year":"2013","journal-title":"Nat. Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pbb.2007.12.011","article-title":"GABAA receptor subtypes underlying general anesthesia","volume":"90","author":"Bonin","year":"2008","journal-title":"Pharmacol. Biochem. Behav"},{"key":"B39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jep.2013.02.004","article-title":"Systems approaches to polypharmacology and drug discovery","volume":"13","author":"Boran","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel"},{"key":"B40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ejca.2011.11.006","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma","volume":"48","author":"Borbath","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0927-7757(99)00277-0","article-title":"Ion transport in lipid bilayer membranes through aqueous pores","volume":"159","author":"Bordi","year":"1999","journal-title":"Coll. Surf. A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"Borisy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000149583","article-title":"The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize","volume":"82","author":"Bosch","year":"2008","journal-title":"Pharmacology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-59745-205-2_5","article-title":"Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy","volume":"448","author":"Bosch","year":"2008","journal-title":"Methods. Mol. Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"Broadhurst","year":"2006","journal-title":"Metabolomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/clpt.2013.81","article-title":"In vitro methods to support transporter evaluation in drug discovery and development","volume":"94","author":"Brouwer","year":"2013","journal-title":"Clin. Pharmacol. Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1002\/pmic.201100039","article-title":"Global absolute quantification of a proteome: challenges in the deployment of a QconCAT strategy","volume":"11","author":"Brownridge","year":"2011","journal-title":"Proteomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cmdc.201100498","article-title":"A decade of the human genome sequence: how does the medicinal chemist benefit?","volume":"7","author":"Brunschweiger","year":"2012","journal-title":"ChemMedChem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"F503","DOI":"10.1152\/ajprenal.00290.2002","article-title":"Transport of cimetidine by flounder and human renal organic anion transporter 1","volume":"284","author":"Burckhardt","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-642-14541-4_2","article-title":"In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy","volume":"201","author":"Burckhardt","year":"2011","journal-title":"Handb. Exp. Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nmeth.2609","article-title":"A reversible gene trap collection empowers haploid genetics in human cells","volume":"10","author":"B\u00c3\u00bcrckst\u00c3\u00bcmmer","year":"2013","journal-title":"Nat. Methods"},{"key":"B52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/AEM.70.2.693-703.2004","article-title":"NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria","volume":"70","author":"Burse","year":"2004a","journal-title":"Appl. Env. Microbiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1094\/MPMI.2004.17.1.43","article-title":"The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora","volume":"17","author":"Burse","year":"2004b","journal-title":"MPMI"},{"key":"B54","volume-title":"How to Mind Map","author":"Buzan","year":"2002"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/bioinformatics\/btq317","article-title":"Molecular signatures-based prediction of enzyme promiscuity","volume":"26","author":"Carbonell","year":"2010","journal-title":"Bioinformatics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.1178955","article-title":"Haploid genetic screens in human cells identify host factors used by pathogens","volume":"326","author":"Carette","year":"2009","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nbt.1857","article-title":"Global gene disruption in human cells to assign genes to phenotypes by deep sequencing","volume":"29","author":"Carette","year":"2011","journal-title":"Nat. Biotechnol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/clpt.2013.161","article-title":"SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink","volume":"94","author":"Carr","year":"2013","journal-title":"Clin. Pharmacol. Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"M111 007633","DOI":"10.1074\/mcp.M111.007633","article-title":"Absolute quantification of the glycolytic pathway in yeast: deployment of a complete QconCAT approach","volume":"10","author":"Carroll","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.4155\/bio.11.232","article-title":"MALDI imaging mass spectrometry: bridging biology and chemistry in drug development","volume":"3","author":"Castellino","year":"2011","journal-title":"Bioanalysis"},{"key":"B61","volume-title":"What is This Thing Called Science?","author":"Chalmers","year":"1999"},{"key":"B62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1754-6834-6-21","article-title":"Transporter engineering for improved tolerance against alkane biofuels in Saccharomyces cerevisiae","volume":"6","author":"Chen","year":"2013","journal-title":"Biotechnol. Biofuels"},{"key":"B63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1039\/c2md00238h","article-title":"A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds","volume":"3","author":"Chen","year":"2012","journal-title":"MedChemComm"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2013.12.013","article-title":"Trends in QconCATs for targeted proteomics","volume":"57","author":"Chen","year":"2014","journal-title":"Trends Anal. Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s11095-011-0438-1","article-title":"The BCS, BDDCS, and regulatory guidances","volume":"28","author":"Chen","year":"2011","journal-title":"Pharm. Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/FPC.0b013e32832cc7e9","article-title":"Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin","volume":"19","author":"Chen","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"M110.001131","DOI":"10.1074\/mcp.M110.001131","article-title":"Proteomic profiling of MDCK plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras\/TGF-{beta}-mediated epithelial-mesenchymal transition.","volume":"10","author":"Chen","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013a","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver","volume":"94","author":"Chu","year":"2013b","journal-title":"Clin. Pharmacol. Ther"},{"key":"B70","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1517\/17425255.2012.656087","article-title":"Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions","volume":"8","author":"Clarke","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/adc.2008.154377","article-title":"Adverse drug reactions in childhood: a review of prospective studies and safety alerts","volume":"94","author":"Clavenna","year":"2009","journal-title":"Arch. Dis. Child"},{"key":"B72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3565(24)37939-X","article-title":"Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2","volume":"288","author":"Collett","year":"1999","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B73","volume-title":"The Overthrow of the Phlogiston theory: the Chemical Revolution of 1775-1789","author":"Conant","year":"1950"},{"key":"B74","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1751-2980.2011.00556.x","article-title":"6-mercaptopurine transport in human lymphocytes: correlation with drug-induced cytotoxicity","volume":"13","author":"Conklin","year":"2012","journal-title":"J. Dig. Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1145\/2494266.2494271","article-title":"PDFX: fully-automated PDF-to-XML conversion of scientific literature","volume":"13","author":"Constantin","year":"2013","journal-title":"DocEng'"},{"key":"B76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"B77","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1021\/ac800617s","article-title":"MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue","volume":"80","author":"Cornett","year":"2008","journal-title":"Anal. Chem"},{"key":"B78","volume-title":"Fundamentals of Enzyme Kinetics, 2nd edn","author":"Cornish-Bowden","year":"1995"},{"key":"B79","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ejps.2005.11.005","article-title":"Development and evaluation of an in vitro method for prediction of human drug absorption - II. Demonstration of the method suitability","volume":"27","author":"Corti","year":"2006","journal-title":"Eur. J. Pharm. Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.str.2011.10.010","article-title":"Cell membranes: the lipid perspective","volume":"19","author":"Coskun","year":"2011","journal-title":"Structure"},{"key":"B81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0166-1280(02)00616-4","article-title":"Pitfalls in QSAR","volume":"622","author":"Cronin","year":"2003","journal-title":"J. Mol. Struct"},{"key":"B82","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","article-title":"Structure and dynamics of molecular networks: a novel paradigm of drug discovery. A comprehensive review","volume":"138","author":"Csermely","year":"2013","journal-title":"Pharmacol. Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.drudis.2012.01.015","article-title":"Relevance of systems pharmacology in drug discovery","volume":"17","author":"Cucurull-Sanchez","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-pharmtox-010611-134743","article-title":"Using genome-wide association studies to identify genes important in serious adverse drug reactions","volume":"52","author":"Daly","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/gm409","article-title":"Pharmacogenomics of adverse drug reactions","volume":"5","author":"Daly","year":"2013","journal-title":"Genome Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/15257770.2011.652330","article-title":"Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine","volume":"31","author":"Damaraju","year":"2012","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B88","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/1078-0432.CCR-13-2293","article-title":"Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity","volume":"20","author":"Damaraju","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/jnc.12315","article-title":"The pre-synaptic Munc13-1 binds alcohol and modulates alcohol self-administration in Drosophila","volume":"126","author":"Das","year":"2013","journal-title":"J. Neurochem"},{"key":"B90","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/MMBR.60.4.641-696.1996","article-title":"Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analysis","volume":"60","author":"Davey","year":"1996","journal-title":"Microbiol. Rev"},{"key":"B91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","article-title":"Adverse drug reactions in hospitals: a narrative review","volume":"2","author":"Davies","year":"2007","journal-title":"Curr. Drug Saf"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS ONE"},{"key":"B93","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010611-134529","article-title":"Drug transporters in drug efficacy and toxicity","volume":"52","author":"Degorter","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chemphyslip.2013.02.007","article-title":"Influence of lipids on protein-mediated transmembrane transport","volume":"169","author":"Denning","year":"2013","journal-title":"Chem. Phys. Lipids"},{"key":"B95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741C","author":"De Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/cc9051","article-title":"Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection","volume":"14","author":"Dickinson","year":"2010","journal-title":"Crit. Care"},{"key":"B97","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/01.anes.0000287061.77674.71","article-title":"Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology","volume":"107","author":"Dickinson","year":"2007","journal-title":"Anesthesiology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1039\/c2mb25512j","article-title":"Yeast cells with impaired drug resistance accumulate glycerol and glucose","volume":"10","author":"Dikicioglu","year":"2014","journal-title":"Mol. Biosyst"},{"key":"B99","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd2438","article-title":"Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?","volume":"7","author":"Dobson","year":"2008","journal-title":"Nat. Rev. Drug Discov"},{"key":"B100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drudis.2008.10.011","article-title":"\u00e2\u20ac\u0153Metabolite-likeness\u00e2\u20ac\u009d as a criterion in the design and selection of pharmaceutical drug libraries","volume":"14","author":"Dobson","year":"2009b","journal-title":"Drug Discov. Today"},{"key":"B101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/156802609787521616","article-title":"Implications of the dominant role of cellular transporters in drug uptake","volume":"9","author":"Dobson","year":"2009a","journal-title":"Curr. Top. Med. Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbamem.2011.08.021","article-title":"Transmembrane helices can induce domain formation in crowded model membranes","volume":"1818","author":"Doma\u00c5\u201eski","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/clpt.2010.255","article-title":"Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study","volume":"89","author":"Donnelly","year":"2011","journal-title":"Clin. Pharmacol. Ther"},{"key":"B104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3565(24)37960-1","article-title":"Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay","volume":"288","author":"D\u00c3\u00b6ppenschmitt","year":"1999","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B105","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1073\/pnas.1301358110","article-title":"Transporter-mediated biofuel secretion","volume":"110","author":"Doshi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B106","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/dna.1985.4.105","article-title":"Genomic clones of Aspergillus nidulans containing alcA, the structural gene for alcohol dehydrogenase and alcR, a regulatory gene for ethanol metabolism","volume":"4","author":"Doy","year":"1985","journal-title":"DNA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-biophys-042910-155245","article-title":"Biomolecular simulation: a computational microscope for molecular biology","volume":"41","author":"Dror","year":"2012","journal-title":"Annu. Rev. Biophys"},{"key":"B108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1109\/MM.2011.38","article-title":"Overcoming communication latency barriers in massively parallel scientific computation","volume":"31","author":"Dror","year":"2011","journal-title":"IEEE Micro"},{"key":"B109","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/sj.bjp.0703518","article-title":"The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers","volume":"131","author":"Dudley","year":"2000","journal-title":"Br. J. Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/msb.2011.21","article-title":"Engineering microbial biofuel tolerance and export using efflux pumps","volume":"7","author":"Dunlop","year":"2011","journal-title":"Mol. Syst. Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1073\/pnas.0712379105","article-title":"Protein area occupancy at the center of the red blood cell membrane","volume":"105","author":"Dupuy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.drudis.2007.01.011","article-title":"Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches","volume":"12","author":"Eckert","year":"2007","journal-title":"Drug Discov. Today"},{"key":"B114","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(24)34865-7","article-title":"Transport of [3H]losartan across isolated perfused rabbit proximal tubule","volume":"290","author":"Edwards","year":"1999","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.shpsa.2011.12.034","article-title":"Epistemic and methodological iteration in scientific research","volume":"43","author":"Elliott","year":"2012","journal-title":"Stud. Hist. Philos. Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1039\/c3an01993d","article-title":"Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy","volume":"139","author":"El-Mashtoly","year":"2014","journal-title":"Analyst"},{"key":"B117","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/clpt.2012.163","article-title":"Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1","volume":"92","author":"Elsby","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B119","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/jpet.109.153130","article-title":"The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-\/- mice","volume":"331","author":"Endres","year":"2009a","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/jpet.108.145854","article-title":"The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or ent1(-\/-) mouse erythrocytes","volume":"329","author":"Endres","year":"2009b","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nature04394","article-title":"Membranes are more mosaic than fluid","volume":"438","author":"Engelman","year":"2005","journal-title":"Nature"},{"key":"B122","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/978-1-62703-017-5_14","article-title":"Simulation studies of the mechanism of membrane transporters","volume":"924","author":"Enkavi","year":"2013","journal-title":"Methods Mol. Biol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1074\/jbc.M508050200","article-title":"Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice","volume":"281","author":"Eraly","year":"2006","journal-title":"J. Biol. Chem"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1289\/ehp.5758","article-title":"Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs","volume":"111","author":"Eriksson","year":"2003","journal-title":"Environ. Health Perspect"},{"key":"B125","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/978-0-387-49785-3_16","article-title":"Prodrugs for liver-targeted drug delivery","volume":"5","author":"Erion","year":"2007","journal-title":"Biotechnol. Pharm. Asp"},{"key":"B126","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/pgs.10.70","article-title":"Drug transporter pharmacogenetics in nucleoside-based therapies","volume":"11","author":"Errasti-Murugarren","year":"2010","journal-title":"Pharmacogenomics"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/03602530903491683","article-title":"Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects","volume":"42","author":"Fahrmayr","year":"2010","journal-title":"Drug Metab. Rev"},{"key":"B129","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1021\/ci0200467","article-title":"Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry","volume":"43","author":"Feher","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/0471140856.tx2303s53","article-title":"Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity","volume":"23","author":"Feng","year":"2012","journal-title":"Curr. Protoc. Toxicol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1021\/mp400295c","article-title":"Quantitative prediction of renal transporter-mediated clinical drug-drug interactions","volume":"10","author":"Feng","year":"2013","journal-title":"Mol. Pharm"},{"key":"B133","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1517\/17460441.2014.922540","article-title":"In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery","volume":"9","author":"Feng","year":"2014","journal-title":"Expert Opin. Drug Discov"},{"key":"B134","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0924-8579(03)00209-7","article-title":"Solvent tolerance in bacteria: role of efflux pumps and cross-resistance with antibiotics","volume":"22","author":"Fernandes","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B135","volume-title":"Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding","author":"Fersht","year":"1999"},{"key":"B136","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2174\/1568026611313070002","article-title":"Intestinal targeting of drugs: rational design approaches and challenges","volume":"13","author":"Filipski","year":"2013","journal-title":"Curr. Top. Med. Chem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1754-6834-6-81","article-title":"Directed evolution of an E. coli inner membrane transporter for improved efflux of biofuel molecules","volume":"6","author":"Foo","year":"2013","journal-title":"Biotechnol. Biofuels"},{"key":"B138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/138161210790112683","article-title":"Pharmacogenetics of drug transporters","volume":"16","author":"Franke","year":"2010","journal-title":"Curr. Pharm. Des"},{"key":"B139","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1086\/508117","article-title":"Exploratory experiments","volume":"72","author":"Franklin","year":"2005","journal-title":"Philos. Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tips.2004.09.003","article-title":"The TREK K2P channels and their role in general anaesthesia and neuroprotection","volume":"25","author":"Franks","year":"2004","journal-title":"Trends Pharmacol. Sci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/310599a0","article-title":"Do general anaesthetics act by competitive binding to specific receptors?","volume":"310","author":"Franks","year":"1984","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/med.2610070104","article-title":"Site-specific drug delivery","volume":"7","author":"Friend","year":"1987","journal-title":"Med. Res. Rev"},{"key":"B143","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/clpt.2012.145","article-title":"Prediction of transporter-mediated drug-drug interactions using endogenous compounds","volume":"92","author":"Fromm","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B144","volume-title":"Drug Transporters","year":"2011"},{"key":"B145","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.01031-10","article-title":"Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats","volume":"55","author":"Fujiwara","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"key":"B146","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10735-012-9406-2","article-title":"An in vivo role of Mrp2 in the rat hepatocytes by immunocytochemistry for amoxicillin using the transporter-deficient EHBR","volume":"43","author":"Fujiwara","year":"2012","journal-title":"J. Mol. Histol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1128\/AAC.00010-10","article-title":"Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes","volume":"54","author":"Furihata","year":"2010","journal-title":"Antimicrob. Agents Chemother"},{"key":"B148","volume-title":"Handbook of Chemoinformatics: From Data to Knowledge","year":"2003"},{"key":"B149","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/cbic.201200628","article-title":"Flexibility and reactivity in promiscuous enzymes","volume":"14","author":"Gatti-Lafranconi","year":"2013","journal-title":"ChemBioChem"},{"key":"B150","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/prot.22601","article-title":"Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer","volume":"78","author":"Gedeon","year":"2010","journal-title":"Proteins"},{"key":"B151","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jprot.2014.03.021","article-title":"MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery","volume":"107","author":"Gessel","year":"2014","journal-title":"J. Proteomics"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2174\/092986712799320682","article-title":"Gemcitabine: a critical nucleoside for cancer therapy","volume":"19","author":"Gesto","year":"2012","journal-title":"Curr. Med. Chem"},{"key":"B153","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejps.2013.10.004","article-title":"Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation","volume":"52","author":"Ghosh","year":"2014","journal-title":"Eur. J. Pharm. Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1200\/JCO.2008.21.1862","article-title":"Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer","volume":"27","author":"Giaccone","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/clpt.2013.12","article-title":"International transporter consortium commentary on clinically important transporter polymorphisms","volume":"94","author":"Giacomini","year":"2013","journal-title":"Clin. Pharmacol. Ther"},{"key":"B156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/clpt.2013.86","article-title":"Transporters in drug development and clinical pharmacology","volume":"94","author":"Giacomini","year":"2013","journal-title":"Clin. Pharmacol. Ther"},{"key":"B157","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"B158","doi-asserted-by":"publisher","first-page":"153ps18","DOI":"10.1126\/scitranslmed.3003471","article-title":"Pharmacogenomics and patient care: one size does not fit all","volume":"4","author":"Giacomini","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1128\/JB.185.21.6448-6455.2003","article-title":"The gene yjcG, cotranscribed with the gene acs, encodes an acetate permease in Escherichia coli","volume":"185","author":"Gimenez","year":"2003","journal-title":"J. Bacteriol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1517\/14656566.2011.563734","article-title":"Pharmacogenomics and adverse drug reactions: the case of statins","volume":"12","author":"Giorgi","year":"2011","journal-title":"Expert Opin. Pharmacother"},{"key":"B161","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1158\/0008-5472.CAN-05-4203","article-title":"Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine","volume":"66","author":"Giovannetti","year":"2006","journal-title":"Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/156802611794480927","article-title":"In-silico ADME models: a general assessment of their utility in drug discovery applications","volume":"11","author":"Gleeson","year":"2011","journal-title":"Curr. Top. Med. Chem"},{"key":"B163","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1025386326946","article-title":"Rational selection of training and test sets for the development of validated QSAR models","volume":"17","author":"Golbraikh","year":"2003","journal-title":"J. Comput. Aided Mol. Des"},{"key":"B164","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2!","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e1003033","DOI":"10.1371\/journal.pcbi.1003033","article-title":"Reduced lateral mobility of lipids and proteins in crowded membranes","volume":"9","author":"Goose","year":"2013","journal-title":"PLoS Comp. Biol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.41.4.439","article-title":"On bimolecular layers of lipoids on the chromocytes of blood","volume":"41","author":"Gorter","year":"1925","journal-title":"J. Exp. Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/FPC.0000000000000048","article-title":"PharmGKB summary: very important pharmacogene information for SLC22A1","volume":"24","author":"Goswami","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.2042-7158.2012.01505.x","article-title":"Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions","volume":"64","author":"Grandvuinet","year":"2012","journal-title":"J. Pharm. Pharmacol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.2174\/138161206778522038","article-title":"Anaesthetic drugs: linking molecular actions to clinical effects","volume":"12","author":"Grasshoff","year":"2006","journal-title":"Curr. Pharm. Des"},{"key":"B170","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","article-title":"The concentrative nucleoside transporter family, SLC28","volume":"447","author":"Gray","year":"2004","journal-title":"Pflugers Arch"},{"key":"B171","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/dmd.112.049312","article-title":"Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement","volume":"41","author":"Grime","year":"2013","journal-title":"Drug Metab. Dispos"},{"key":"B172","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1124\/mol.65.2.443","article-title":"Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane","volume":"65","author":"Gruss","year":"2004","journal-title":"Mol. Pharmacol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11030-006-9054-0","article-title":"Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness","volume":"11","author":"Gupta","year":"2007","journal-title":"Mol. Divers"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00210-012-0781-8","article-title":"Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3","volume":"385","author":"Haenisch","year":"2012","journal-title":"Arch Pharmacol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/ SLC21 family: phylogenetic classification as OATP\/ SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"B176","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"B177","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1593\/neo.10576","article-title":"Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells","volume":"12","author":"Hagmann","year":"2010","journal-title":"Neoplasia"},{"key":"B178","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1158\/1078-0432.CCR-07-4118","article-title":"Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer","volume":"14","author":"Hamada","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/ci300512q","article-title":"BioSM: metabolomics tool for identifying endogenous mammalian biochemical structures in chemical structure space","volume":"53","author":"Hamdalla","year":"2013","journal-title":"J. Chem. Inf. Model"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s12272-011-1107-y","article-title":"Role of transporters in drug interactions","volume":"34","author":"Han","year":"2011","journal-title":"Arch. Pharm. Res"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1073\/pnas.1317890111","article-title":"Water access points and hydration pathways in CLC H+\/Cl\u00e2\u02c6\u2019 transporters","volume":"111","author":"Han","year":"2014","journal-title":"Proc. Natl. Acad. Sci.U.S.A"},{"key":"B182","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/ajh.2010.191","article-title":"Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide","volume":"24","author":"Han","year":"2011","journal-title":"Am. J. Hypertens"},{"key":"B183","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1039\/c1md00017a","article-title":"Molecular obesity, potency and other addictions in drug discovery","volume":"2","author":"Hann","year":"2011","journal-title":"MedChemComm"},{"key":"B184","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/bdd.1810","article-title":"Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption","volume":"34","author":"Harwood","year":"2013","journal-title":"Biopharm. Drug Dispos"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2004","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B186","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug saf"},{"key":"B187","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1479-7364-3-2-195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Hum. genomics"},{"key":"B188","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): introduction","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nbt1492","article-title":"A consensus yeast metabolic network obtained from a community approach to systems biology","volume":"26","author":"Herrg\u00c3\u00a5rd","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/sj.emboj.7600234","article-title":"TREK-1, a K+ channel involved in neuroprotection and general anesthesia","volume":"23","author":"Heurteaux","year":"2004","journal-title":"EMBO J"},{"key":"B191","volume-title":"The Fourth Paradigm: Data-Intensive Scientific Discovery","year":"2009"},{"key":"B192","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-Knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"B193","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01329-2","article-title":"Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics","volume":"49","author":"Hinderling","year":"1997","journal-title":"Pharmacol. Rev"},{"key":"B194","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)12995-9","article-title":"On the mechanism of intestinal absorption of drugs","volume":"125","author":"Hogben","year":"1959","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B195","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","article-title":"Can we rationally design promiscuous drugs?","volume":"16","author":"Hopkins","year":"2006","journal-title":"Curr. Opin. Struct. Biol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10157-011-0460-y","article-title":"Roles of organic anion\/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins","volume":"15","author":"Hosoya","year":"2011","journal-title":"Clin. Exp. Nephrol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.1073\/pnas.1104480108","article-title":"Structural basis for alcohol modulation of a pentameric ligand-gated ion channel","volume":"108","author":"Howard","year":"2011a","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1530-0277.2011.01502.x","article-title":"Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution","volume":"35","author":"Howard","year":"2011b","journal-title":"Alcohol. Clin. Exp. Res"},{"key":"B200","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/pr.113.007468","article-title":"Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics","volume":"66","author":"Howard","year":"2014","journal-title":"Pharmacol. Rev"},{"key":"B201","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1158\/0008-5472.CAN-03-3884","article-title":"Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance","volume":"64","author":"Huang","year":"2004","journal-title":"Cancer Res"},{"key":"B202","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S1359-6446(03)02654-0","article-title":"Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach","volume":"8","author":"Huang","year":"2003","journal-title":"Drug Discov. Today"},{"key":"B203","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B204","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/mp300410n","article-title":"Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification","volume":"10","author":"Incecayir","year":"2013","journal-title":"Mol. Pharm"},{"key":"B205","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"B206","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J. Pharm. Sci"},{"key":"B207","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00424-003-1093-0","article-title":"Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35)","volume":"447","author":"Ishida","year":"2004","journal-title":"Pflugers Arch"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ph6111347","article-title":"Metabolic interactions of purine derivatives with human ABC transporter ABCG2: genetic testing to assess gout risk","volume":"6","author":"Ishikawa","year":"2013a","journal-title":"Pharmaceuticals"},{"key":"B209","volume-title":"Pharmacogenomics of Human Drug Transporters: Clinical Impacts","year":"2013b"},{"key":"B210","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1517\/phgs.5.1.67.25683","article-title":"The genetic polymorphism of drug transporters: functional analysis approaches","volume":"5","author":"Ishikawa","year":"2004","journal-title":"Pharmacogenomics"},{"key":"B211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3565(24)37760-2","article-title":"Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide","volume":"287","author":"Ishizuka","year":"1998","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B212","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1254\/jphs.SC0070291","article-title":"Mouse organic anion transporter 2 (mOat2) mediates the transport of short chain fatty acid propionate","volume":"106","author":"Islam","year":"2008","journal-title":"J. Pharmacol. Sci"},{"key":"B213","volume-title":"The Bimolecular Lipid Membrane","author":"Jain","year":"1972"},{"key":"B214","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1039\/c2md20242e","article-title":"On the origins of drug polypharmacology","volume":"4","author":"Jalencas","year":"2013","journal-title":"MedChemComm"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1105\/tpc.13.5.1095","article-title":"A plant plasma membrane ATP binding cassette-type transporter is involved in antifungal terpenoid secretion","volume":"13","author":"Jasi\u00c5\u201eski","year":"2001","journal-title":"Plant Cell"},{"key":"B216","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1039\/c2fd20085f","article-title":"Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes","volume":"161","author":"Javanainen","year":"2013","journal-title":"Faraday Discuss"},{"key":"B217","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2217\/pgs.12.186","article-title":"Systems pharmacology meets predictive, preventive, personalized and participatory medicine","volume":"14","author":"Jenkins","year":"2013","journal-title":"Pharmacogenomics"},{"key":"B218","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1124\/jpet.111.188037","article-title":"The TM2 6\u00e2\u20ac\u00b2 position of GABAA receptors mediates alcohol inhibition","volume":"340","author":"Johnson","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"B219","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2217\/bmm.13.48","article-title":"Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer?","volume":"7","author":"Jordheim","year":"2013","journal-title":"Biomark. Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/S0024-3205(01)01296-6","article-title":"Characterization of ochratoxin A transport by human organic anion transporters","volume":"69","author":"Jung","year":"2001","journal-title":"Life Sci"},{"key":"B221","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1096\/fj.02-0611fje","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor \u00ce\u00b23 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.bbagen.2013.09.037","article-title":"Aquaporins and membrane diffusion of CO2 in living organisms","volume":"1840","author":"Kaldenhoff","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B223","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1021\/ci0601517","article-title":"Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds","volume":"46","author":"Karakoc","year":"2006","journal-title":"J. Chem. Inf. Model"},{"key":"B224","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J. Med. Chem"},{"key":"B225","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1073\/pnas.0408930102","article-title":"Molecular dynamics and protein function","volume":"102","author":"Karplus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B226","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm"},{"key":"B227","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/jps.21618","article-title":"Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol","volume":"98","author":"Kato","year":"2009","journal-title":"J. Pharm. Sci"},{"key":"B228","volume-title":"Basic Enzyme Kinetics","author":"Keleti","year":"1986"},{"key":"B229","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/B978-0-12-152833-1.50021-6","article-title":"The protonmotive force as an intermediate in electron transport-linked phosphorylation: problems and prospects","volume":"33","author":"Kell","year":"1992","journal-title":"Curr. Top. Cell. Regul"},{"key":"B230","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1742-4658.2006.05136.x","article-title":"Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor B\u00c3\u00bccher lecture","volume":"273","author":"Kell","year":"2006","journal-title":"FEBS J"},{"key":"B231","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/bies.201100144","article-title":"Scientific discovery as a combinatorial optimisation problem: how best to navigate the landscape of possible experiments?","volume":"34","author":"Kell","year":"2012","journal-title":"Bioessays"},{"key":"B232","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1111\/febs.12268","article-title":"Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening, and knowledge of transporters: where drug discovery went wrong and how to fix it","volume":"280","author":"Kell","year":"2013","journal-title":"FEBS J"},{"key":"B233","first-page":"149","article-title":"The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology,","volume-title":"Proc Int Beilstein Symposium on Systems Chemistry","author":"Kell","year":"2009"},{"key":"B234","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","article-title":"The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so","volume":"18","author":"Kell","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B235","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.drudis.2011.05.010","article-title":"Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only","volume":"16","author":"Kell","year":"2011","journal-title":"Drug Discov. Today"},{"key":"B236","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0005-2728(78)90136-6","article-title":"Measurement by a flow dialysis technique of the steady-state protonmotive force in chromatophores from Rhodospirillum rubrum: comparison with the phosphorylation potential","volume":"502","author":"Kell","year":"1978a","journal-title":"Biochim. Biophys. Acta"},{"key":"B237","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.drudis.2013.07.014","article-title":"Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery","volume":"19","author":"Kell","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B238","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bj1740257","article-title":"The protonmotive force in phosphorylating membrane vesicles from Paracoccus denitrificans: magnitude, sites of generation and comparison with the phosphorylation potential","volume":"174","author":"Kell","year":"1978b","journal-title":"Biochem. J"},{"key":"B239","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1000664013047","article-title":"Viability and activity in readily culturable bacteria: a review and discussion of the practical issues","volume":"73","author":"Kell","year":"1998","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7551\/mitpress\/9780262195485.003.0001","article-title":"The role of modeling in systems biology,","volume-title":"System Modeling in Cellular Biology: from Concepts to Nuts and Bolts","author":"Kell","year":"2006"},{"key":"B241","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-022X(80)90013-5","article-title":"Formulation and some biological uses of a buffer mixture whose buffering capacity is relatively independent of pH in the range pH 4\u00e2\u20ac\u201c9","volume":"3","author":"Kell","year":"1980","journal-title":"J. Biochem. Biophys. Methods"},{"key":"B242","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/bies.10385","article-title":"Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era","volume":"26","author":"Kell","year":"2004","journal-title":"Bioessays"},{"key":"B243","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0006-291X(81)91715-0","article-title":"On the permeability to weak acids and bases of the cytoplasmic membrane of Clostridium pasteurianum","volume":"99","author":"Kell","year":"1981","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B244","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00430362","article-title":"Quantifying heterogeneity: flow cytometry of bacterial cultures","volume":"60","author":"Kell","year":"1991","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B245","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0167-7799(00)89006-X","article-title":"GMP - Good modelling practice: an essential component of good manufacturing practice","volume":"13","author":"Kell","year":"1995","journal-title":"Trends Biotechnol"},{"key":"B246","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1574-6968.1986.tb01863.x","article-title":"Metabolic control theory: its role in microbiology and biotechnology","volume":"39","author":"Kell","year":"1986","journal-title":"FEMS Microbiol. Rev"},{"key":"B247","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10822-014-9757-8","article-title":"Ligand efficiency metrics considered harmful","volume":"28","author":"Kenny","year":"2014","journal-title":"J. Comput. Aided Mol. Des"},{"key":"B248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-398339-8.00001-X","article-title":"Membrane transporters in drug development","volume":"63","author":"Keogh","year":"2012","journal-title":"Adv. Pharmacol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.sbi.2009.02.011","article-title":"Molecular dynamics simulations of membrane channels and transporters","volume":"19","author":"Khalili-Araghi","year":"2009","journal-title":"Curr. Opin. Struct. Biol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B251","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1471-2105-10-S15-S10","article-title":"Physicochemical property space distribution among human metabolites, drugs and toxins","volume":"10","author":"Khanna","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"B252","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1758-2946-3-30","article-title":"Structural diversity of biologically interesting datasets: a scaffold analysis approach","volume":"3","author":"Khanna","year":"2011","journal-title":"J. Cheminform"},{"key":"B253","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1021\/ac060788p","article-title":"Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry","volume":"78","author":"Khatib-Shahidi","year":"2006","journal-title":"Anal. Chem"},{"key":"B254","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-biochem-030409-143718","article-title":"Enzyme promiscuity: a mechanistic and evolutionary perspective","volume":"79","author":"Khersonsky","year":"2010","journal-title":"Annu. Rev. Biochem"},{"key":"B255","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4161\/derm.3.2.14816","article-title":"Role of fatty acid transporters in epidermis: implications for health and disease","volume":"3","author":"Khnykin","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"B256","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1021\/jm2001629","article-title":"Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2","volume":"54","author":"Kido","year":"2011","journal-title":"J. Med. Chem"},{"key":"B257","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1074\/jbc.273.1.85","article-title":"Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance","volume":"273","author":"Kieboom","year":"1998a","journal-title":"J. Biol. Chem"},{"key":"B258","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1128\/JB.180.24.6769-6772.1998","article-title":"Active efflux of organic solvents by Pseudomonas putida S12 is induced by solvents","volume":"180","author":"Kieboom","year":"1998b","journal-title":"J. Bacteriol"},{"key":"B259","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tips.2006.06.004","article-title":"Nucleoside transporters: from scavengers to novel therapeutic targets","volume":"27","author":"King","year":"2006","journal-title":"Trends Pharmacol. Sci"},{"key":"B260","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s11095-012-0942-y","article-title":"Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions","volume":"30","author":"Kis","year":"2013","journal-title":"Pharm. Res"},{"key":"B261","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2133\/dmpk.DMPK-11-RV-084","article-title":"Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters","volume":"27","author":"Kiyotani","year":"2012","journal-title":"Drug Metab. Pharmacokinet"},{"key":"B262","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/pharmaceutics3040680","article-title":"Transporter-mediated drug\u00e2\u20ac\u201cdrug interactions with oral antidiabetic drugs","volume":"3","author":"Klatt","year":"2011","journal-title":"Pharmaceutics"},{"key":"B263","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1124\/dmd.108.022418","article-title":"High-affinity interaction of sartans with H+\/peptide transporters","volume":"37","author":"Kn\u00c3\u00bctter","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B264","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1124\/jpet.108.143339","article-title":"Transport of angiotensin-converting enzyme inhibitors by H+\/peptide transporters revisited","volume":"327","author":"Kn\u00c3\u00bctter","year":"2008","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B265","doi-asserted-by":"publisher","first-page":"e63635","DOI":"10.1371\/journal.pone.0063635","article-title":"Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations","volume":"8","author":"Kolds\u00c3\u00b8","year":"2013","journal-title":"PLoS One"},{"key":"B266","doi-asserted-by":"publisher","first-page":"3498-3502","DOI":"10.1021\/jz301570w","article-title":"Local lipid reorganization by a transmembrane protein domain","volume":"3","author":"Kolds\u00c3\u00b8","year":"2012","journal-title":"J. Phys. Chem. Lett"},{"key":"B267","doi-asserted-by":"publisher","first-page":"936893","DOI":"10.5402\/2011\/936893","article-title":"Novel strategy with gemcitabine for advanced pancreatic cancer","volume":"2011","author":"Komori","year":"2011","journal-title":"ISRN Oncol"},{"key":"B268","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1345\/aph.1L037","article-title":"Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies","volume":"42","author":"Kongkaew","year":"2008","journal-title":"Ann Pharmacother"},{"key":"B269","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-14541-4_1","article-title":"Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms","volume":"201","author":"K\u00c3\u00b6nig","year":"2011","journal-title":"Handb. Exp. Pharmacol"},{"key":"B270","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"K\u00c3\u00b6nig","year":"2013","journal-title":"Pharmacol. Rev"},{"key":"B271","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11095-012-0926-y","article-title":"Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier","volume":"30","author":"Kubo","year":"2013a","journal-title":"Pharm. Res"},{"key":"B272","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1002\/jps.23535","article-title":"Propranolol transport across the inner blood-retinal barrier: potential involvement of a novel organic cation transporter","volume":"102","author":"Kubo","year":"2013b","journal-title":"J. Pharm. Sci"},{"key":"B273","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.tibs.2011.08.001","article-title":"Hierarchical mesoscale domain organization of the plasma membrane","volume":"36","author":"Kusumi","year":"2011","journal-title":"Trends Biochem. Sci"},{"key":"B274","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bmcl.2011.12.002","article-title":"Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series","volume":"22","author":"Lachance","year":"2012a","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B275","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bmcl.2011.10.070","article-title":"Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series","volume":"22","author":"Lachance","year":"2012b","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B276","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature13419","article-title":"Membrane proteins bind lipids selectively to modulate their structure and function","volume":"510","author":"Laganowsky","year":"2014","journal-title":"Nature"},{"key":"B277","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2174\/13816128113199990467","article-title":"Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development","volume":"20","author":"Lai","year":"2014","journal-title":"Curr. Pharmaceut. Des"},{"key":"B278","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2174\/138620710790596772","article-title":"Evaluation of drug transporter interactions in drug discovery and development. Comb. Chem. High Throughput Screen 13","author":"Lai","year":"2010"},{"key":"B279","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1517\/17425255.2012.678048","article-title":"Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability\u00e2\u20ac\u201d-considerations for drug development","volume":"8","author":"Lai","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"B280","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1208\/aapsj060321","article-title":"Transporter and ion channel gene expression after Caco-2 cell differentiation using 2 different microarray technologies","volume":"6","author":"Landowski","year":"2004","journal-title":"AAPS J"},{"key":"B281","doi-asserted-by":"publisher","first-page":"O3","DOI":"10.1186\/1758-2946-3-S1-O3","article-title":"Making sure there's a \u00e2\u20ac\u0153give\u00e2\u20ac\u009d associated with the \u00e2\u20ac\u0153take\u00e2\u20ac\u009d: producing and using open-source software in big pharma","volume":"3","author":"Landrum","year":"2011","journal-title":"J. Cheminform"},{"key":"B282","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1741-7007-9-70","article-title":"Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast","volume":"9","author":"Lanthaler","year":"2011","journal-title":"BMC Biol"},{"key":"B283","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B284","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tibs.2011.06.007","article-title":"Biological membranes: the importance of molecular detail","volume":"36","author":"Lee","year":"2011a","journal-title":"Trends Biochem. Sci"},{"key":"B285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1201\/b11018-14","article-title":"How to understand lipid\u00e2\u20ac\u201cprotein interactions in biological membranes,","volume-title":"The Structure of Biological Membranes, 3rd Edn","author":"Lee","year":"2011b"},{"key":"B286","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/187152010794474019","article-title":"Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents","volume":"10","author":"Lee","year":"2010","journal-title":"Anticancer Agents Med. Chem"},{"key":"B287","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ejca.2013.11.028","article-title":"Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy","volume":"50","author":"Lee","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"B288","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov"},{"key":"B289","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nchembio.120","article-title":"Combination chemical genetics","volume":"4","author":"Leh\u00c3\u00a1r","year":"2008","journal-title":"Nat. Chem. Biol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejps.2013.10.012","article-title":"Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo","volume":"57","author":"Lennern\u00c3\u00a4s","year":"2014","journal-title":"Eur. J. Pharm. Sci"},{"key":"B291","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/S0006-3495(04)74275-7","article-title":"Molecular dynamics simulations of hydrophilic pores in lipid bilayers","volume":"86","author":"Leontiadou","year":"2004","journal-title":"Biophys. J"},{"key":"B292","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1529\/biophysj.106.101295","article-title":"Ion transport across transmembrane pores","volume":"92","author":"Leontiadou","year":"2007","journal-title":"Biophys. J"},{"key":"B293","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1517\/17425255.2012.667401","article-title":"Renal drug-drug interactions: what we have learned and where we are going","volume":"8","author":"Lepist","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"B294","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.bbagen.2013.11.004","article-title":"Plant aquaporins: roles in plant physiology","volume":"1840","author":"Li","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B295","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/PGPM.S18861","article-title":"Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy","volume":"4","author":"Li","year":"2011","journal-title":"Pharmacogenomics Pers. Med"},{"key":"B296","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbamem.2011.10.026","article-title":"The role of membrane thickness in charged protein-lipid interactions","volume":"1818","author":"Li","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B297","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/dmd.105.006791","article-title":"Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters","volume":"34","author":"Li","year":"2006","journal-title":"Drug Metab. Dispos"},{"key":"B298","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejps.2008.06.008","article-title":"Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human","volume":"35","author":"Li","year":"2008","journal-title":"Eur. J. Pharm. Sci"},{"key":"B299","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbalip.2013.09.016","article-title":"Fatty acid transporters in skin development, function and disease","volume":"1841","author":"Lin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B300","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1126\/science.1208351","article-title":"How fast-folding proteins fold","volume":"334","author":"Lindorff-Larsen","year":"2011","journal-title":"Science"},{"key":"B301","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1754-6834-6-95","article-title":"Transcriptome response to alkane biofuels in Saccharomyces cerevisiae: identification of efflux pumps involved in alkane tolerance","volume":"6","author":"Ling","year":"2013","journal-title":"Biotechnol. Biofuels"},{"key":"B302","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u00e2\u20ac\u201ca genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"B303","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol"},{"key":"B304","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev"},{"key":"B305","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/9781118354483","article-title":"Stearoyl-CoA Desaturase 1 (SCD1) inhibitors: bench to bedside must only go through liver","author":"Liu","year":"2013","journal-title":"RSC Drug Discov"},{"key":"B306","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0074-7742(04)65003-3","article-title":"Sites of alcohol and volatile anesthetic action on glycine receptors","volume":"65","author":"Lobo","year":"2005","journal-title":"Int. Rev. Neurobiol"},{"key":"B307","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pbb.2008.03.006","article-title":"GABAA receptors and alcohol","volume":"90","author":"Lobo","year":"2008","journal-title":"Pharmacol. Biochem. Behav"},{"key":"B308","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/ATVBAHA.106.126714","article-title":"Physiological roles of vascular nucleoside transporters","volume":"27","author":"L\u00c3\u00b6ffler","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"B309","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2174\/138920008784746337","article-title":"The challenges of dealing with promiscuous drug-metabolizing enzymes, receptors and transporters","volume":"9","author":"Ma","year":"2008","journal-title":"Curr. Drug Metab"},{"key":"B310","first-page":"4349","article-title":"Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines","volume":"58","author":"Mackey","year":"1998","journal-title":"Cancer Res"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/jnci\/91.21.1876","article-title":"Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters","volume":"91","author":"Mackey","year":"1999","journal-title":"J. Natl. Cancer Inst"},{"key":"B312","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.mam.2012.10.012","article-title":"Transporter biology in drug approval: regulatory aspects","volume":"34","author":"Maeda","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"B313","first-page":"99","article-title":"What kind of assumptions should we use to improve the predictability of drug-drug interactions involving organic anion transporting polypeptide (OATP) substrates?","volume":"43","author":"Maeda","year":"2011","journal-title":"Drug Metab. Rev"},{"key":"B314","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-12-394423-8.00006-8","article-title":"Supramolecular organization in prokaryotic respiratory systems","volume":"61","author":"Magalon","year":"2012","journal-title":"Adv. Microb. Physiol"},{"key":"B315","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry","volume":"57","author":"Maggiora","year":"2014","journal-title":"J. Med. Chem"},{"key":"B316","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11584380-000000000-00000","article-title":"Clinical implications of pharmacogenetic variation on the effects of statins","volume":"34","author":"Maggo","year":"2011","journal-title":"Drug Saf"},{"key":"B317","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11030-006-8697-1","article-title":"Molecular similarity and diversity in chemoinformatics: from theory to applications","volume":"10","author":"Maldonado","year":"2006","journal-title":"Mol. Divers"},{"key":"B318","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1476-5381.2011.01618.x","article-title":"Interaction of innovative small molecule drugs used for cancer therapy with drug transporters","volume":"165","author":"Mandery","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"B319","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejphar.2003.08.076","article-title":"Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney","volume":"479","author":"Mangravite","year":"2003","journal-title":"Eur. J. Pharmacol"},{"key":"B320","first-page":"895","article-title":"Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma","volume":"91","author":"Marc\u00c3\u00a9","year":"2006","journal-title":"Haematologica"},{"key":"B321","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1634\/theoncologist.12-8-927","article-title":"Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)","volume":"12","author":"Marchetti","year":"2007","journal-title":"Oncologist"},{"key":"B322","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.gastro.2012.06.006","article-title":"Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma","volume":"143","author":"Mar\u00c3\u00a9chal","year":"2012","journal-title":"Gastroenterology"},{"key":"B323","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/1078-0432.CCR-08-2080","article-title":"Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma","volume":"15","author":"Mar\u00c3\u00a9chal","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"B324","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jprot.2011.03.019","article-title":"Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging","volume":"74","author":"Marko-Varga","year":"2011","journal-title":"J. Proteomics"},{"key":"B325","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2001-1326-1-8","article-title":"Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine","volume":"1","author":"Marko-Varga","year":"2012","journal-title":"Clin. Transl. Med"},{"key":"B326","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-61779-213-7_3","article-title":"Mechanisms of drug interactions II: transport proteins,","volume-title":"Drug Interactions in Infectious Diseases, 3rd Edn.","author":"Marzolini","year":"2011"},{"key":"B327","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1124\/dmd.108.023911","article-title":"The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine","volume":"37","author":"Matsushima","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B328","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejps.2014.05.017","article-title":"Drug delivery: a process governed by species-specific lipophilicities","volume":"62C","author":"Maz\u00c3\u00a1k","year":"2014","journal-title":"Eur. J. Pharm. Sci"},{"key":"B329","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2174\/156802612804910331","article-title":"Drug discovery applications for KNIME: an open source data mining platform","volume":"12","author":"Mazanetz","year":"2012","journal-title":"Curr. Top. Med. Chem"},{"key":"B330","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/bj1960311","article-title":"Estimation with an ion-selective electrode of the membrane potential in cells of Paracoccus denitrificans from the uptake of the butyltriphenylphosphonium cation during aerobic and anaerobic respiration","volume":"196","author":"Mccarthy","year":"1981","journal-title":"Biochem. J"},{"key":"B331","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature04398","article-title":"Plasma membrane phosphoinositide organization by protein electrostatics","volume":"438","author":"Mclaughlin","year":"2005","journal-title":"Nature"},{"key":"B332","volume-title":"Pluto's Republic","author":"Medawar","year":"1982"},{"key":"B333","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B334","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1124\/mol.109.062687","article-title":"Alcohol- and alcohol antagonist-sensitive human GABAA receptors: tracking delta subunit incorporation into functional receptors","volume":"78","author":"Meera","year":"2010","journal-title":"Mol. Pharmacol"},{"key":"B335","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.tips.2009.07.004","article-title":"Conciliating binding efficiency and polypharmacology","volume":"30","author":"Mestres","year":"2009","journal-title":"Trends Pharmacol. Sci"},{"key":"B336","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cbpa.2010.06.166","article-title":"Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks","volume":"14","author":"Metz","year":"2010","journal-title":"Curr. Opin. Chem. Biol"},{"key":"B337","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/S0140-6736(00)03167-6","article-title":"Pharmacogenetics and adverse drug reactions","volume":"356","author":"Meyer","year":"2000","journal-title":"Lancet"},{"key":"B338","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3309","article-title":"Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis","volume":"21","author":"Miguel","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"B339","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/38738","article-title":"Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors","volume":"389","author":"Mihic","year":"1997","journal-title":"Nature"},{"key":"B340","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/dmd.108.025254","article-title":"Carrier-mediated uptake of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-napht ho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small-molecule survivin suppressant, into human solid tumor and lymphoma cells","volume":"37","author":"Minematsu","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B341","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/dmd.109.028142","article-title":"Characterization of human organic cation transporter 1 (OCT1\/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant","volume":"38","author":"Minematsu","year":"2010","journal-title":"Drug Metab. Dispos"},{"key":"B342","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/dmd.108.024083","article-title":"Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters","volume":"37","author":"Ming","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B343","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1124\/dmd.110.033092","article-title":"Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogs","volume":"38","author":"Miraglia","year":"2010","journal-title":"Drug Metab. Dispos"},{"key":"B344","doi-asserted-by":"publisher","first-page":"e02740","DOI":"10.7554\/eLife.02740","article-title":"Conformational dynamics of the nucleotide binding domains and the power stroke of a heterodimeric ABC transporter","volume":"3","author":"Mishra","year":"2014","journal-title":"Elife e"},{"key":"B345","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1073\/pnas.0307332101","article-title":"Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol","volume":"101","author":"Mitra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B346","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuint.2007.07.010","article-title":"Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol","volume":"52","author":"Mody","year":"2008","journal-title":"Neurochem. Int"},{"key":"B347","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/15257771003729823","article-title":"Role of nucleoside transporters in nucleoside-derived drug sensitivity","volume":"29","author":"Molina-Arcas","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B348","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/15257770802145819","article-title":"Physiological and pharmacological roles of nucleoside transporter proteins","volume":"27","author":"Molina-Arcas","year":"2008","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"B349","doi-asserted-by":"publisher","first-page":"18916","DOI":"10.1073\/pnas.1313202110","article-title":"Mechanistic picture for conformational transition of a membrane transporter at atomic resolution","volume":"110","author":"Moradi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B350","first-page":"1201","article-title":"Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells","volume":"17","author":"Mori","year":"2007","journal-title":"Oncol. Rep"},{"key":"B351","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1124\/dmd.104.001552","article-title":"Functional involvement of rat organic anion transporter 2 (SLC22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen","volume":"33","author":"Morita","year":"2005","journal-title":"Drug Metab. Dispos"},{"key":"B352","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF-FDA transportal: a public drug transporter database","volume":"92","author":"Morrissey","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B353","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s11064-012-0857-3","article-title":"Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT)","volume":"37","author":"Moschen","year":"2012","journal-title":"Neurochem. Res"},{"key":"B354","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejphar.2004.09.032","article-title":"Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)","volume":"503","author":"Motohashi","year":"2004","journal-title":"Eur. J. Pharmacol"},{"key":"B355","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tips.2010.11.007","article-title":"Emerging role for drug transporters at the blood-testis barrier","volume":"32","author":"Mruk","year":"2011","journal-title":"Trends Pharmacol. Sci"},{"key":"B356","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/09687688.2012.687461","article-title":"From mosaic to patchwork: matching lipids and proteins in membrane organization","volume":"29","author":"Mueller","year":"2012","journal-title":"Mol. Membr. Biol"},{"key":"B357","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(24)38862-7","article-title":"Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1","volume":"295","author":"Mulato","year":"2000","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B358","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug-drug interactions","volume":"12","author":"M\u00c3\u00bcller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"B359","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"M\u00c3\u00bcller","year":"2005","journal-title":"Biochem. Pharmacol"},{"key":"B360","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tibs.2012.11.006","article-title":"What makes a P450 tick?","volume":"38","author":"Munro","year":"2013","journal-title":"Trends Biochem. Sci"},{"key":"B361","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nucmedbio.2012.10.002","article-title":"Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model","volume":"40","author":"Murakami","year":"2013","journal-title":"Nucl. Med. Biol"},{"key":"B362","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00534-011-0440-3","article-title":"Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy","volume":"19","author":"Murata","year":"2012","journal-title":"J. Hepatobiliary Pancreat. Sci"},{"key":"B363","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharm. Sci"},{"key":"B364","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.surg.2012.10.010","article-title":"Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection","volume":"153","author":"Nakagawa","year":"2013","journal-title":"Surgery"},{"key":"B365","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1349-7006.2010.01834.x","article-title":"Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models","volume":"102","author":"Nakahara","year":"2011","journal-title":"Cancer Sci"},{"key":"B366","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1056\/NEJMe0805136","article-title":"Pharmacogenomics and drug toxicity","volume":"359","author":"Nakamura","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"B367","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2133\/dmpk.DMPK-11-RV-099","article-title":"Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs","volume":"27","author":"Nakanishi","year":"2012","journal-title":"Drug Metab. Pharmacokinet"},{"key":"B368","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.bjc.6603559","article-title":"Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells","volume":"96","author":"Nakano","year":"2007","journal-title":"Br. J. Cancer"},{"key":"B369","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/scientificamerican0392-44","article-title":"The patch clamp technique","volume":"266","author":"Neher","year":"1992","journal-title":"Sci. Am"},{"key":"B370","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1517\/17425255.2012.722996","article-title":"Multidrug and toxin extrusion (MATE) proteins as transporters of antimicrobial drugs","volume":"8","author":"Nies","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"B371","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy","author":"Nies","year":"2011","journal-title":"Handb. Exp. Pharmacol"},{"key":"B372","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1586\/ecp.10.60","article-title":"Organic cation transporter pharmacogenomics and drug-drug interaction","volume":"3","author":"Nies","year":"2010","journal-title":"Expert Rev. Clin. Pharmacol"},{"key":"B373","doi-asserted-by":"publisher","first-page":"e11411","DOI":"10.1371\/journal.pone.0011411","article-title":"Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry","volume":"5","author":"Nilsson","year":"2010","journal-title":"PLoS ONE"},{"key":"B374","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jbiotec.2013.03.003","article-title":"ABC transporters and cell wall proteins involved in organic solvent tolerance in Saccharomyces cerevisiae","volume":"165","author":"Nishida","year":"2013","journal-title":"J. Biotechnol"},{"key":"B375","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nbt1519","article-title":"Protein promiscuity and its implications for biotechnology","volume":"27","author":"Nobeli","year":"2009","journal-title":"Nat. Biotechnol"},{"key":"B376","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.3748\/wjg.v20.i26.8482","article-title":"hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review","volume":"20","author":"Nordh","year":"2014","journal-title":"World J. Gasteroenterol"},{"key":"B377","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature09647","article-title":"X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel","volume":"469","author":"Nury","year":"2011","journal-title":"Nature"},{"key":"B378","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha 5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"B379","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1021\/jm200319u","article-title":"Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia","volume":"54","author":"Oballa","year":"2011","journal-title":"J. Med. Chem"},{"key":"B380","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1016\/S1074-5521(99)80033-7","article-title":"Catalytic promiscuity and the evolution of new enzymatic activities","volume":"6","author":"O'brien","year":"1999","journal-title":"Chem. Biol"},{"key":"B381","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1124\/mol.112.081083","article-title":"Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics","volume":"83","author":"Obuchi","year":"2013","journal-title":"Mol. Pharmacol"},{"key":"B382","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2007.06.012","article-title":"The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer","volume":"256","author":"Oguri","year":"2007","journal-title":"Cancer Lett"},{"key":"B383","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-11014-10733-z","article-title":"A \u00e2\u20ac\u0153rule of 0.5\u00e2\u20ac\u009d for the metabolite-likeness of approved pharmaceutical drugs","author":"O'Hagan","year":"2014","journal-title":"Metabolomics"},{"key":"B384","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/mp3004308","article-title":"Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model","volume":"10","author":"Ohtsuki","year":"2013","journal-title":"Mol. Pharm"},{"key":"B385","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1002\/jps.22612","article-title":"Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects","volume":"100","author":"Ohtsuki","year":"2011","journal-title":"J. Pharm. Sci"},{"key":"B386","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.alcohol.2007.04.006","article-title":"GABAA receptor subtypes: the \u00e2\u20ac\u0153one glass of wine\u00e2\u20ac\u009d receptors","volume":"41","author":"Olsen","year":"2007","journal-title":"Alcohol"},{"key":"B387","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0925-4439(02)00074-1","article-title":"A simple model to predict blood-brain barrier permeation from 3D molecular fields","volume":"1587","author":"Ooms","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"B388","volume-title":"Chemoinformatics in Drug Discovery","year":"2004"},{"key":"B389","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1039\/c3cy00091e","article-title":"Substrate promiscuity of cytochrome P450 RhF","volume":"3","author":"O'reilly","year":"2013","journal-title":"Catal. Sci. Technol"},{"key":"B390","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1039\/c0cc03165h","article-title":"Cytochromes P450 as useful biocatalysts: addressing the limitations","volume":"47","author":"O'reilly","year":"2011","journal-title":"Chem. Commun. (Camb)"},{"key":"B391","first-page":"88","article-title":"\u00c3\u0153ber die allgemeinen osmotischen Eigenschaften der Zelle, ihre vermutliche Ursachen und ihre Bedeutung f\u00c3\u00bcr die Physiologie","volume":"44","author":"Overton","year":"1899","journal-title":"Vierteljahrsschr. Naturforsch. Ges. Z\u00c3\u00bcrich"},{"key":"B392","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/dmd.110.035063","article-title":"Tissue distribution and characterization of drug-related material in rats and dogs after repeated oral administration of casopitant","volume":"39","author":"Pagliarusco","year":"2011","journal-title":"Drug Metab. Dispos"},{"key":"B393","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/hep.510280524","article-title":"The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein","volume":"28","author":"Pang","year":"1998","journal-title":"Hepatology"},{"key":"B394","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"B395","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B396","doi-asserted-by":"publisher","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr. Top. Med. Chem"},{"key":"B397","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/221844a0","article-title":"Energy of an ion crossing a low dielectric membrane: solutions to four relevant electrostatic problems","volume":"221","author":"Parsegian","year":"1969","journal-title":"Nature"},{"key":"B398","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/8084","article-title":"Inhalational anesthetics activate two-pore-domain background K+ channels","volume":"2","author":"Patel","year":"1999","journal-title":"Nat. Neurosci"},{"key":"B399","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1124\/jpet.104.073916","article-title":"Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine","volume":"312","author":"Pavek","year":"2005","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B400","doi-asserted-by":"publisher","first-page":"e28966","DOI":"10.1371\/journal.pone.0028966","article-title":"Understanding and classifying metabolite space and metabolite-likeness","volume":"6","author":"Peironcely","year":"2011","journal-title":"PLoS ONE"},{"key":"B401","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1128\/JB.186.20.6885-6890.2004","article-title":"A pH-sensitive function and phenotype: evidence that EutH facilitates diffusion of uncharged ethanolamine in Salmonella enterica","volume":"186","author":"Penrod","year":"2004","journal-title":"J. Bacteriol"},{"key":"B402","first-page":"185","article-title":"A human protein atlas based on antibody proteomics","volume":"8","author":"Persson","year":"2006","journal-title":"Curr. Opin. Mol. Ther"},{"key":"B403","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.1021\/jm400856t","article-title":"Polypharmacology - foe or friend?","volume":"56","author":"Peters","year":"2013","journal-title":"J. Med. Chem"},{"key":"B404","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1517\/17460441.2013.748744","article-title":"Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes","volume":"8","author":"Pfefferkorn","year":"2013","journal-title":"Expert Opin. Drug Discov"},{"key":"B405","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/jm2014887","article-title":"Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotini c acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus","volume":"55","author":"Pfefferkorn","year":"2012","journal-title":"J. Med. Chem"},{"key":"B406","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1016\/j.bmcl.2010.11.103","article-title":"Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution","volume":"21","author":"Pfefferkorn","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B407","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1073\/pnas.1218321110","article-title":"Atomic-level description of ubiquitin folding","volume":"110","author":"Piana","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B408","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/978-3-642-00663-0_17","article-title":"Pharmacogenetics of idiosyncratic adverse drug reactions","volume":"196","author":"Pirmohamed","year":"2010","journal-title":"Handb. Exp. Pharmacol"},{"key":"B409","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.drudis.2011.08.006","article-title":"Pharmacogenetics: past, present and future","volume":"16","author":"Pirmohamed","year":"2011","journal-title":"Drug Discov. Today"},{"key":"B410","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000335613","article-title":"Genetics and the potential for predictive tests in adverse drug reactions","volume":"97","author":"Pirmohamed","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"key":"B411","doi-asserted-by":"publisher","first-page":"f1","DOI":"10.1136\/bmj.f1","article-title":"Drug-grapefruit juice interactions: two mechanisms are clear but individual responses vary","volume":"346","author":"Pirmohamed","year":"2013","journal-title":"BMJ"},{"key":"B412","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-genom-090413-025419","article-title":"Personalized pharmacogenomics: predicting efficacy and adverse drug reactions","volume":"15","author":"Pirmohamed","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet"},{"key":"B413","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"B414","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B415","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The human protein atlas\u00e2\u20ac\u201ca tool for pathology","volume":"216","author":"Pont\u00c3\u00a9n","year":"2008","journal-title":"J. Pathol"},{"key":"B416","volume-title":"Conjectures and Refutations: The Growth of Scientific Knowledge, 5th Edn","author":"Popper","year":"1992"},{"key":"B417","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1016\/j.bmcl.2011.10.040","article-title":"Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy","volume":"21","author":"Powell","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B418","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nprot.2006.129","article-title":"Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes","volume":"1","author":"Pratt","year":"2006","journal-title":"Nat. Protoc"},{"key":"B419","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/pmic.200600956","article-title":"Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells","volume":"7","author":"Pshezhetsky","year":"2007","journal-title":"Proteomics"},{"key":"B420","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1208\/s12248-014-9607-6","article-title":"Quantitative targeted proteomics for membrane transporter proteins: method and application","volume":"16","author":"Qiu","year":"2014","journal-title":"AAPS J"},{"key":"B421","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/BJ20071460","article-title":"A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites","volume":"411","author":"Quashie","year":"2008","journal-title":"Biochem. J"},{"key":"B422","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1475-2875-9-36","article-title":"Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter","volume":"9","author":"Quashie","year":"2010","journal-title":"Malar. J"},{"key":"B423","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1006\/bbrc.1998.9978","article-title":"Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3)","volume":"255","author":"Race","year":"1999","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"B424","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/clpt.2014.125","article-title":"The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update","volume":"96","author":"Ramsey","year":"2014","journal-title":"Clin. Pharmacol. Ther"},{"key":"B425","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1016\/j.bmcl.2011.08.037","article-title":"Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors","volume":"21","author":"Ramtohul","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B426","first-page":"6075","article-title":"Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity","volume":"60","author":"Rauchwerger","year":"2000","journal-title":"Cancer Res"},{"key":"B427","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/Prot.24098","article-title":"Refinement of protein structure homology models via long, all-atom molecular dynamics simulations","volume":"80","author":"Raval","year":"2012","journal-title":"Proteins"},{"key":"B428","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1073\/pnas.1018098108","article-title":"A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin","volume":"108","author":"Reiling","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B429","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.tox.2011.09.048","article-title":"Transporter mediated uptake and efflux of antiretroviral drugs: potential for drug-drug interactions","volume":"290","author":"Riches","year":"2011","journal-title":"Toxicology"},{"key":"B430","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Riedmaier","year":"2012","journal-title":"Pharmacol. Rev"},{"key":"B431","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/nl1038874","article-title":"Controlled translocation of individual DNA molecules through protein nanopores with engineered molecular brakes","volume":"11","author":"Rincon-Restrepo","year":"2011","journal-title":"Nano Lett"},{"key":"B432","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1074\/mcp.M600456-MCP200","article-title":"Absolute multiplexed quantitative analysis of protein expression during muscle development using QconCAT","volume":"6","author":"Rivers","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"B433","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1002\/anie.200905559","article-title":"Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging","volume":"49","author":"R\u00c3\u00b6mpp","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"B434","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00216-011-4990-7","article-title":"Mass spectrometry imaging with high resolution in mass and space (HR2 MSI) for reliable investigation of drug compound distributions on the cellular level","volume":"401","author":"R\u00c3\u00b6mpp","year":"2011","journal-title":"Anal. Bioanal. Chem"},{"key":"B435","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1038\/psp.2014.24","article-title":"Application of a physiologically based pharmacokinetic model to predict OATP1B1-related variability in pharmacodynamics of rosuvastatin","volume":"3","author":"Rose","year":"2014","journal-title":"CPT Pharmacometrics Syst. Pharmacol"},{"key":"B436","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/clpt.2012.65","article-title":"Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology","volume":"92","author":"Rostami-Hodjegan","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B437","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00280-013-2210-1","article-title":"DMET (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity","volume":"72","author":"Rumiato","year":"2013","journal-title":"Cancer Chemother. Pharmacol"},{"key":"B438","author":"Russell","year":"1947","journal-title":"Am I An Atheist or An Agnostic?"},{"key":"B439","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J. Proteome Res"},{"key":"B440","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.bcp.2012.01.032","article-title":"The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1","volume":"83","author":"Saadatmand","year":"2012","journal-title":"Biochem. Pharmacol"},{"key":"B441","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tim.2008.09.007","article-title":"Drug:H+ antiporters in chemical stress response in yeast","volume":"17","author":"S\u00c3\u00a1-Correia","year":"2009","journal-title":"Trends Microbiol"},{"key":"B442","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1359-6446(04)03198-8","article-title":"Transporter-mediated drug delivery: recent progress and experimental approaches","volume":"9","author":"Sai","year":"2004","journal-title":"Drug Discov. Today"},{"key":"B443","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev.ph.46.030184.002323","article-title":"Patch clamp techniques for studying ionic channels in excitable membranes","volume":"46","author":"Sakmann","year":"1984","journal-title":"Annu. Rev. Physiol"},{"key":"B444","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1467-7652.2007.00254.x","article-title":"Coupling the GAL4 UAS system with alcR for versatile cell type-specific chemically inducible gene expression in Arabidopsis","volume":"5","author":"Sakvarelidze","year":"2007","journal-title":"Plant Biotechnol. J"},{"key":"B445","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1113\/jphysiol.2006.107904","article-title":"Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1","volume":"574","author":"Sala-Rabanal","year":"2006","journal-title":"J. Physiol"},{"key":"B446","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/bja\/aeg232","article-title":"Xenon: no stranger to anaesthesia","volume":"91","author":"Sanders","year":"2003","journal-title":"Br. J. Anaesth"},{"key":"B447","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.alcohol.2007.04.011","article-title":"Ethanol acts directly on extrasynaptic subtypes of GABAA receptors to increase tonic inhibition","volume":"41","author":"Santhakumar","year":"2007","journal-title":"Alcohol"},{"key":"B448","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/156800911793743600","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)","volume":"11","author":"Santini","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"B449","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/BJ20130412","article-title":"SATP (YaaH), a succinate-acetate transporter protein in Escherichia coli","volume":"454","author":"S\u00c3\u00a1-Pessoa","year":"2013","journal-title":"Biochem. J"},{"key":"B450","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1248\/bpb.33.498","article-title":"Renal secretion of uric acid by organic anion transporter 2 (OAT2\/SLC22A7) in human","volume":"33","author":"Sato","year":"2010","journal-title":"Biol. Pharm. Bull"},{"key":"B451","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/1568026611313070007","article-title":"Molecular modeling and ligand docking for solute carrier (SLC) transporters","volume":"13","author":"Schlessinger","year":"2013a","journal-title":"Curr. Top. Med. Chem"},{"key":"B452","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/clpt.2013.73","article-title":"SLC classification: an update","volume":"94","author":"Schlessinger","year":"2013b","journal-title":"Clin. Pharmacol. Ther"},{"key":"B453","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/3-540-29784-7_8","article-title":"Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency","volume":"175","author":"Sch\u00c3\u00b6mig","year":"2006","journal-title":"Handb. Exp. Pharmacol"},{"key":"B454","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1021\/jm021012t","article-title":"Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery","volume":"46","author":"Schwab","year":"2003","journal-title":"J. Med. Chem"},{"key":"B455","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1021\/ac3015142","article-title":"Evaluation of an accurate mass approach for the simultaneous detection of drug and metabolite distributions via whole-body mass spectrometric imaging","volume":"84","author":"Shahidi-Latham","year":"2012","journal-title":"Anal. Chem"},{"key":"B456","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/bi301086x","article-title":"Visualizing functional motions of membrane transporters with molecular dynamics simulations","volume":"52","author":"Shaikh","year":"2013","journal-title":"Biochemistry"},{"key":"B457","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1464-410X.2008.07629.x","article-title":"A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer","volume":"102","author":"Sharifi","year":"2008","journal-title":"BJU Int"},{"key":"B458","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejps.2012.04.003","article-title":"Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins","volume":"47","author":"Sharma","year":"2012","journal-title":"Eur. J. Pharm. Sci"},{"key":"B459","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1145\/1364782.1364802","article-title":"Anton, a special-purpose machine for molecular dynamics simulation","volume":"51","author":"Shaw","year":"2008","journal-title":"Commun. ACM"},{"key":"B460","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1021\/ci049782w","article-title":"Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR","volume":"44","author":"Sheridan","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"B461","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.vascn.2005.08.003","article-title":"Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane","volume":"53","author":"Shilling","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B462","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","article-title":"Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions","volume":"26","author":"Shitara","year":"2011","journal-title":"Drug Metab. Pharmacokinet"},{"key":"B463","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ejps.2005.12.003","article-title":"Transporters as a determinant of drug clearance and tissue distribution","volume":"27","author":"Shitara","year":"2006","journal-title":"Eur. J. Pharm. Sci"},{"key":"B464","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/bdd.1823","article-title":"Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption","volume":"34","author":"Shitara","year":"2013","journal-title":"Biopharm. Drug Dispos"},{"key":"B465","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2217\/pgs.09.154","article-title":"Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform","volume":"11","author":"Sissung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"B466","first-page":"19","article-title":"Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy","volume":"13","author":"Sissung","year":"2012","journal-title":"Discov. Med"},{"key":"B467","doi-asserted-by":"publisher","first-page":"e39360","DOI":"10.1371\/journal.pone.0039360","article-title":"A steered molecular dynamics study of binding and translocation processes in the GABA transporter","volume":"7","author":"Skovstrup","year":"2012","journal-title":"PLoS ONE"},{"key":"B468","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/onc.2012.179","article-title":"The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the concentrative nucleoside transporter family","volume":"32","author":"Skrypek","year":"2013","journal-title":"Oncogene"},{"key":"B469","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbamem.2011.06.015","article-title":"Lipid-protein interactions in biological membranes: a dynamic perspective","volume":"1818","author":"Smith","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B470","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm"},{"key":"B471","doi-asserted-by":"publisher","first-page":"e24061","DOI":"10.1371\/journal.pone.0024061","article-title":"Adverse drug reactions in children\u00e2\u20ac\u201ca systematic review","volume":"7","author":"Smyth","year":"2012","journal-title":"PLoS ONE"},{"key":"B472","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pro.2385","article-title":"Cholesterol as a co-solvent and a ligand for membrane proteins","volume":"23","author":"Song","year":"2014","journal-title":"Protein Sci"},{"key":"B473","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.mam.2012.12.004","article-title":"Roles of the nucleotide sugar transporters (SLC35 family) in health and disease","volume":"34","author":"Song","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"B474","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/bj1740237","article-title":"The protonmotive force in bovine heart submitochondrial particles: magnitude, sites of generation and comparison with the phosphorylation potential","volume":"174","author":"Sorgato","year":"1978","journal-title":"Biochem. J"},{"key":"B475","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1158\/1078-0432.CCR-04-0224","article-title":"The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma","volume":"10","author":"Spratlin","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"B476","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.drup.2012.01.009","article-title":"Contribution of tumoral and host solute carriers to clinical drug response","volume":"15","author":"Sprowl","year":"2012","journal-title":"Drug Resist. Updat"},{"key":"B477","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/clpt.2012.167","article-title":"Drug trafficking: recent advances in therapeutics and disease","volume":"92","author":"Sprowl","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B478","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1124\/dmd.113.055806","article-title":"Uptake carriers and oncology drug safety","volume":"42","author":"Sprowl","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"B479","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/00498250801927435","article-title":"Physiology, structure, and regulation of the cloned organic anion transporters","volume":"38","author":"Srimaroeng","year":"2008","journal-title":"Xenobiotica"},{"key":"B480","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ddr.21050","article-title":"Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactions","volume":"74","author":"Stankov","year":"2013","journal-title":"Drug Dev. Res"},{"key":"B481","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.str.2013.03.005","article-title":"Multiscale simulations reveal conserved patterns of lipid interactions with aquaporins","volume":"21","author":"Stansfeld","year":"2013","journal-title":"Structure"},{"key":"B482","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.str.2011.10.002","article-title":"Molecular simulation approaches to membrane proteins","volume":"19","author":"Stansfeld","year":"2011","journal-title":"Structure"},{"key":"B483","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1016\/j.bmcl.2013.10.057","article-title":"Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia","volume":"23","author":"Stevens","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B484","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2217\/pgs.11.53","article-title":"Pharmacogenetics of drug transporters in the enterohepatic circulation","volume":"12","author":"Stieger","year":"2011","journal-title":"Pharmacogenomics"},{"key":"B485","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.1073\/pnas.0901054106","article-title":"Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore","volume":"106","author":"Stoddart","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B486","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/jb.177.5.1357-1366.1995","article-title":"Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster","volume":"177","author":"Stojiljkovic","year":"1995","journal-title":"J. Bacteriol"},{"key":"B487","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich's magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"B488","volume-title":"Transporters in Drug Development: Discovery, Optimization, Clinical Study and Regulation","year":"2013"},{"key":"B489","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.bmcl.2013.12.035","article-title":"Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects","volume":"24","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"B490","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1021\/jm300684u","article-title":"Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes","volume":"55","author":"Sutherland","year":"2012","journal-title":"J. Med. Chem"},{"key":"B491","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s11306-013-0564-3","article-title":"An analysis of a \u00e2\u20ac\u0153community-driven\u00e2\u20ac\u009d reconstruction of the human metabolic network","volume":"9","author":"Swainston","year":"2013","journal-title":"Metabolomics"},{"key":"B492","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2045-8118-8-13","article-title":"Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders","volume":"8","author":"Tachikawa","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"B493","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.2042-7158.2011.01389.x","article-title":"Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters","volume":"64","author":"Takanohashi","year":"2012","journal-title":"J. Pharm. Pharmacol"},{"key":"B494","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.coph.2013.09.001","article-title":"OATP transporter-mediated drug absorption and interaction","volume":"13","author":"Tamai","year":"2013","journal-title":"Curr. Opin. Pharmacol"},{"key":"B495","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1177\/1087057113494807","article-title":"Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research","volume":"18","author":"Tang","year":"2013","journal-title":"J. Biomol. Screen"},{"key":"B496","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1586\/17512433.2014.910111","article-title":"Understanding and preventing drug-drug and drug-gene interactions","volume":"7","author":"Tannenbaum","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol"},{"key":"B497","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1475-2859-11-98","article-title":"Increased expression of the yeast multidrug resistance ABC transporter Pdr18 leads to increased ethanol tolerance and ethanol production in high gravity alcoholic fermentation","volume":"11","author":"Teixeira","year":"2012","journal-title":"Microb. Cell Fact"},{"key":"B498","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1128\/AEM.00845-09","article-title":"Genome-wide identification of Saccharomyces cerevisiae genes required for maximal tolerance to ethanol","volume":"75","author":"Teixeira","year":"2009","journal-title":"Appl. Env. Microbiol"},{"key":"B499","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nbt.2488","article-title":"A community-driven global reconstruction of human metabolism","volume":"31","author":"Thiele","year":"2013","journal-title":"Nat. Biotechnol"},{"key":"B500","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1471-4892(01)00013-3","article-title":"Mechanism of action of general anaesthetics: new information from molecular pharmacology","volume":"1","author":"Thompson","year":"2001","journal-title":"Curr. Opin. Pharmacol"},{"key":"B501","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4419-7937-7_13","article-title":"The clinical significance of drug transporters in drug disposition and drug interactions,","volume-title":"Pharmacokinetics in Drug Development, Vol. 3, Advances and Applications","author":"Thompson","year":"2011"},{"key":"B502","volume-title":"Bilayer Lipid Membranes (BLM): Theory and Practice","author":"Tien","year":"1974"},{"key":"B503","volume-title":"Planar Lipid Bilayers (BLMs) and Their Applications","year":"2003"},{"key":"B504","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-642-14541-4_10","article-title":"Molecular mechanisms of drug transporter regulation","volume":"201","author":"Tirona","year":"2011","journal-title":"Handb. Exp. Pharmacol"},{"key":"B505","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2133\/dmpk.25.122","article-title":"Prediction of severe adverse drug reactions using pharmacogenetic biomarkers","volume":"25","author":"Tohkin","year":"2010","journal-title":"Drug Metab. Pharmacokinet"},{"key":"B506","first-page":"118","article-title":"Paclitaxel enhances cellular uptake of gemcitabine through up-regulation of nucleoside transporters CNT1 and CNT3","volume":"45","author":"Tong","year":"2014","journal-title":"Drug Metab. Rev"},{"key":"B507","doi-asserted-by":"publisher","first-page":"26391","DOI":"10.1074\/jbc.M111.249292","article-title":"Deletion of multispecific organic anion transporter (OAT1\/SLC22A6) protects from mercury-induced kidney injury","volume":"286","author":"Torres","year":"2011","journal-title":"J. Biol. Chem"},{"key":"B508","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/1471-2407-12-434","article-title":"Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs","volume":"12","author":"Trigueros-Motos","year":"2012","journal-title":"BMC Cancer"},{"key":"B509","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform"},{"key":"B510","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/qsar.200390007","article-title":"The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models","volume":"22","author":"Tropsha","year":"2003","journal-title":"QSAR Comb. Sci"},{"key":"B511","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/clpt.2014.55","article-title":"Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach","volume":"96","author":"Tsamandouras","year":"2014","journal-title":"Clin. Pharmacol. Ther"},{"key":"B512","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/jpet.108.147918","article-title":"Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells","volume":"329","author":"Tsuda","year":"2009","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B513","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1128\/JB.182.17.4803-4810.2000","article-title":"Entry into and release of solvents by Escherichia coli in an organic-aqueous two-liquid-phase system and substrate specificity of the AcrAB-TolC solvent-extruding pump","volume":"182","author":"Tsukagoshi","year":"2000","journal-title":"J. Bacteriol"},{"key":"B514","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/ph7020169","article-title":"The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs","volume":"7","author":"Tsume","year":"2014","journal-title":"Pharmaceuticals"},{"key":"B515","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/1568026611313070008","article-title":"Medicinal chemistry design principles for liver targeting through OATP transporters","volume":"13","author":"Tu","year":"2013","journal-title":"Curr. Top. Med. Chem"},{"key":"B516","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1128\/JB.01410-10","article-title":"Role of dihydrolipoamide dehydrogenase in regulation of raffinose transport in Streptococcus pneumoniae","volume":"193","author":"Tyx","year":"2011","journal-title":"J. Bacteriol"},{"key":"B517","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1124\/jpet.111.184200","article-title":"Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice","volume":"339","author":"Uchida","year":"2011a","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B518","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011b","journal-title":"J. Neurochem"},{"key":"B519","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2045-8118-10-21","article-title":"A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS\/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL\/6J mice","volume":"10","author":"Uchida","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"B520","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1124\/mol.61.4.729","article-title":"Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition","volume":"61","author":"Uchino","year":"2002","journal-title":"Mol. Pharmacol"},{"key":"B521","volume-title":"Adverse Drug Reactions","year":"2010"},{"key":"B522","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38896-2","article-title":"Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1","volume":"295","author":"Uwai","year":"2000a","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B523","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-2999(00)00837-2","article-title":"Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter","volume":"409","author":"Uwai","year":"2000b","journal-title":"Eur. J. Pharmacol"},{"key":"B524","doi-asserted-by":"publisher","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"B525","doi-asserted-by":"publisher","first-page":"13008","DOI":"10.1073\/pnas.1305563110","article-title":"Importance of lipid-pore loop interface for potassium channel structure and function","volume":"110","author":"Van Der Cruijsen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B526","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s11095-011-0467-9","article-title":"Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development","volume":"28","author":"Van Der Graaf","year":"2011","journal-title":"Pharm. Res"},{"key":"B527","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1021\/mp200103h","article-title":"pH-Sensitive Interaction of HMG-CoA Reductase Inhibitors (Statins) with organic anion transporting polypeptide 2B1","volume":"8","author":"Varma","year":"2011","journal-title":"Mol. Pharm"},{"key":"B528","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1007\/s11095-012-0792-7","article-title":"Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions","volume":"29","author":"Varma","year":"2012","journal-title":"Pharm. Res"},{"key":"B529","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.ddtec.2014.03.004","article-title":"Transporter taxonomy - a comparison of different transport protein classification schemes","volume":"12","author":"Viereck","year":"2014","journal-title":"Drug Discov. Today Technol"},{"key":"B530","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1124\/dmd.113.056309","article-title":"Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions","volume":"42","author":"Vildhede","year":"2014","journal-title":"Drug Metab. Dispos"},{"key":"B531","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1099\/mic.0.078477-0","article-title":"Identification of a novel ATP-binding cassette transporter involved in long-chain fatty acid import and its role in triacylglycerol accumulation in Rhodococcus jostii RHA1","volume":"160","author":"Villalba","year":"2014","journal-title":"Microbiology"},{"key":"B532","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4155\/fmc.11.149","article-title":"Drug-permeability and transporter assays in Caco-2 and MDCK cell lines","volume":"3","author":"Volpe","year":"2011","journal-title":"Future Med. Chem"},{"key":"B533","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SLCO1B1*5 genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J. Am. Coll. Cardiol"},{"key":"B534","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI103852","article-title":"Calculation of intracellular pH from the distribution of 5,5-dimethyl-2,4-oxazolidinedione (DMO); application to skeletal muscle of the dog","volume":"38","author":"Waddell","year":"1959","journal-title":"J. Clin. Invest"},{"key":"B535","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/clpt.2012.151","article-title":"Advancing pharmacometrics and systems pharmacology","volume":"92","author":"Waldman","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B536","doi-asserted-by":"publisher","first-page":"15218","DOI":"10.1073\/pnas.2435171100","article-title":"Ethanol enhances alpha4beta3delta and alpha6beta3delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans","volume":"100","author":"Wallner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B537","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1073\/pnas.0600194103","article-title":"Low-dose alcohol actions on alpha 4 beta 3 delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513","volume":"103","author":"Wallner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B538","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17460441.2012.648612","article-title":"Going further than Lipinski's rule in drug design","volume":"7","author":"Walters","year":"2012","journal-title":"Exp. Opin. Drug Discov"},{"key":"B539","first-page":"3171","article-title":"Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1","volume":"31","author":"Wang","year":"2011","journal-title":"Anticancer Res"},{"key":"B540","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/chir.20753","article-title":"Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers","volume":"22","author":"Wang","year":"2010a","journal-title":"Chirality"},{"key":"B541","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1152\/physiol.00046.2009","article-title":"Exploring transmembrane diffusion pathways with molecular dynamics","volume":"25","author":"Wang","year":"2010b","journal-title":"Physiology"},{"key":"B542","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15376510701795306","article-title":"Importance of drug transporters in pharmacokinetics and drug safety","volume":"18","author":"Ward","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"B543","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1093\/hmg\/dds341","article-title":"Pharmacogenomics of adverse drug reactions: implementing personalized medicine","volume":"21","author":"Wei","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"B545","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.febslet.2009.11.018","article-title":"Systems biology: the elements and principles of life","volume":"583","author":"Westerhoff","year":"2009","journal-title":"FEBS Lett"},{"key":"B546","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/clpt.2012.57","article-title":"The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy","volume":"92","author":"Wilke","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B547","volume-title":"Biochemical Individuality","author":"Williams","year":"1956"},{"key":"B548","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nchembio.1590","article-title":"The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity","volume":"10","author":"Winter","year":"2014","journal-title":"Nat. Chem. Biol"},{"key":"B549","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2337\/db06-0749","article-title":"Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue","volume":"55","author":"Wu","year":"2006a","journal-title":"Diabetes"},{"key":"B550","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1128\/MCB.26.9.3455-3467.2006","article-title":"FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity","volume":"26","author":"Wu","year":"2006b","journal-title":"Mol. Cell Biol"},{"key":"B551","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0005-2736(00)00189-9","article-title":"Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta","volume":"1466","author":"Wu","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"B552","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5754\/hge12687","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) predicts the Asian patient response to gemcitabine-based chemotherapy in pancreatic cancer","volume":"60","author":"Xiao","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"B553","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010611-134630","article-title":"Novel computational approaches to polypharmacology as a means to define responses to individual drugs","volume":"52","author":"Xie","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B554","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0006-2952(98)00017-3","article-title":"19F NMR study of the uptake of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil in erythrocytes: evidence of transport by facilitated and nonfacilitated pathways","volume":"55","author":"Xu","year":"1998","journal-title":"Biochem. Pharmacol"},{"key":"B555","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.febslet.2005.12.009","article-title":"ABC transporters involved in the transport of plant secondary metabolites","volume":"580","author":"Yazaki","year":"2006","journal-title":"FEBS Lett"},{"key":"B556","first-page":"S47","article-title":"Application of physiologically based pharmacokinetic (PBPK) modeling for prediction of complex drug-drug interactions (DDIs) involving OATPIB1-mediated uptake and cytochrome P450 (Cyp) metabolism and multiple inhibitors","volume":"91","author":"Yeo","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B557","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/ecp.13.4","article-title":"Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach","volume":"6","author":"Yeo","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol"},{"key":"B558","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/tpj.2012.42","article-title":"Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications","volume":"13","author":"Yiannakopoulou","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"B559","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","author":"Yip","year":"2014","journal-title":"Clin. Rev. Allergy Immunol"},{"key":"B560","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1476-5381.2011.01394.x","article-title":"Importance of the multidrug and toxin extrusion MATE\/SLC47A family to pharmacokinetics, pharmacodynamics\/toxicodynamics and pharmacogenomics","volume":"164","author":"Yonezawa","year":"2011","journal-title":"Br. J. Pharmacol"},{"key":"B561","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/clpt.2011.351","article-title":"Transporter-mediated drug-drug interactions involving OATP substrates: predictions based on in vitro inhibition studies","volume":"91","author":"Yoshida","year":"2012","journal-title":"Clin. Pharmacol. Ther"},{"key":"B562","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev-pharmtox-011112-140309","article-title":"Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms","volume":"53","author":"Yoshida","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B563","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol. Aspects Med"},{"key":"B564","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/clpt.2013.45","article-title":"ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans","volume":"94","author":"Zamek-Gliszczynski","year":"2013","journal-title":"Clin. Pharmacol. Ther"},{"key":"B565","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/ci1003015","article-title":"Characterizing the diversity and biological relevance of the MLPCN assay manifold and screening set","volume":"51","author":"Zhang","year":"2011a","journal-title":"J. Chem. Inf. Model"},{"key":"B566","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/clpt.2010.359","article-title":"Transporter-mediated drug-drug interactions","volume":"89","author":"Zhang","year":"2011b","journal-title":"Clin. Pharmacol. Ther"},{"key":"B567","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/toxsci\/kft085","article-title":"Detection of statin cytotoxicity is increased in cells expressing the OATP1B1 transporter","volume":"134","author":"Zhang","year":"2013","journal-title":"Toxicol. Sci"},{"key":"B568","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/chir.22178","article-title":"Stereoselective accumulation of propranolol enantiomers in K562 and K562\/ADR cells","volume":"25","author":"Zheng","year":"2013","journal-title":"Chirality"},{"key":"B569","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2337\/db08-0896","article-title":"Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study","volume":"58","author":"Zhou","year":"2009","journal-title":"Diabetes"},{"key":"B570","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/03602532.2014.887094","article-title":"Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction","volume":"46","author":"Zhou","year":"2014","journal-title":"Drug Metab. Rev"},{"key":"B571","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"B572","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/clpt.2010.354","article-title":"Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions","volume":"89","author":"Zolk","year":"2011","journal-title":"Clin. Pharmacol. Ther"},{"key":"B573","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1021\/mp500152y","article-title":"The low\/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol","volume":"11","author":"Zur","year":"2014","journal-title":"Mol Pharm"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:30:04Z","timestamp":1746477004000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2014.00231\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":572,"URL":"https:\/\/doi.org\/10.3389\/fphar.2014.00231","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}